Vasculogenic mimicry in small cell lung cancer

SC Williamson, RL Metcalf, F Trapani, S Mohan… - Nature …, 2016 - nature.com
… , vasculogenic mimicry (VM) describes the ability of aggressive tumour cells to trans-differentiate,
acquiring endothelial cell … generation of tumour-derived vascular networks and a micro-…

Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry

S Wu, L Yu, D Wang, L Zhou, Z Cheng, D Chai, L Ma… - BMC cancer, 2012 - Springer
… protein and vasculogenic mimicry (VM) in primary non-small cell lung cancer (NSCLC). …
that CSCs may be related to angiogenesis and vasculogenic mimicry. CSCs have self-renewal …

The role of sema4D in vasculogenic mimicry formation in non‐small cell lung cancer and the underlying mechanisms

Y Xia, XY Cai, JQ Fan, LL Zhang… - … journal of cancer, 2019 - Wiley Online Library
… -small cell lung cancers (NSCLCs). Vasculogenic mimicry (VM), the formation of vascular
networks composed of aggressive cancer cells, may be one of the reasons. our study explored …

[HTML][HTML] Vasculogenic mimicry and expression of slug and vimentin correlate with metastasis and prognosis in non-small cell lung cancer

H Song, H Ci, J Xu, Z Xu, Y Zhang, Y Wang… - … Journal of Clinical …, 2018 - ncbi.nlm.nih.gov
… cause of cancer death in recent years, its morbidity and mortality were increasing yearly. The
presence of vasculogenic mimicry (VM) is associated with a high tumor grade, short survival…

[PDF][PDF] Vasculogenic mimicry and cancer stem-like cell markers are associated with poor prognosis of non-small cell lung cancer

HZ Sun, DF Zhang, LL Yao, XL Zhao, XM Zhao… - Int. J. Clin. Exp …, 2016 - e-century.us
… [Vasculogenic mimicry in tongue squamous cell carcinoma]. Nan Fang Yi … vasculogenic
mimicry in colorectal cancer through induction of epithelial-to-mesenchymal transition. Cancer

Genetic, phenotypic and functional characterisation of vasculogenic mimicry in small-cell lung cancer

F Trapani, S Williamson, RL Metcalf, HS Leong… - Cancer Research, 2016 - AACR
… angiogenesis-independent tumor vascularisation pathways warrant further investigation.
Vasculogenic mimicry (VM) is the ability of tumor cells to mimic endothelial cells by trans-…

Thrombin is a therapeutic target for non-small-cell lung cancer to inhibit vasculogenic mimicry formation

B Zhao, M Wu, Z Hu, Y Ma, W Qi, Y Zhang… - Signal transduction and …, 2020 - nature.com
Tumor cells transform into endothelial cells by epithelial-to-mesenchymal transition, which
is characterized by vasculogenic mimicry (VM). VM not only accelerates tumor progression …

Dickkopf‐1‐promoted vasculogenic mimicry in non‐small cell lung cancer is associated with EMT and development of a cancer stem‐like cell phenotype

L Yao, D Zhang, X Zhao, B Sun, Y Liu… - Journal of Cellular …, 2016 - Wiley Online Library
… ) towards the induction of vasculogenic mimicry (VM) in non-small cell lung cancer (NSCLC),
we … Vasculogenic mimicry was observed in 28 of 205 NSCLC tumours, while DKK1 was …

Cyclin-dependent kinase 5 controls vasculogenic mimicry formation in non-small cell lung cancer via the FAK-AKT signaling pathway

X Zhou, R Gu, X Han, G Wu, J Liu - Biochemical and biophysical research …, 2017 - Elsevier
tumor cell plasticity via VM formation. In this study, we demonstrate the existence of VM in
non-small cell lung carcinoma. … FAK/AKT downstream signaling in non-small cell carcinoma. …

Angiomotin-p130 inhibits vasculogenic mimicry formation of small cell lung cancer independently of Smad2/3 signal pathway

D Li, Y Shen, H Ren, L Wang, J Yang… - Journal of Bioenergetics …, 2021 - Springer
vasculogenic mimicry (VM) formation of SCLC. We confirmed that Amot-p130 expression
was reduced in lung cancer … of SCLC cancer lines, and compared with the control cells, Amot-…